As of the latest Form 4 filed Jun 12, 2026.
What Intuitive Surgical Inc insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 73 most recent filings for ISRG.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-12 | 2026-06-12 | Brosius Mark EVP & Chief Mfg and Supply Cha | SSale | −25.00 | $414.13 | $10.4K | Yes (planned) | Form 4 ↗ |
| 2026-06-12 | 2026-06-11 | Brosius Mark, EVP & Chief Mfg and Supply Cha | SSale | −23.00 | $412.16 | $9.48K | Yes (planned) | Form 4 ↗ |
| 2026-06-10 | 2026-06-10 | Brosius Mark EVP & Chief Mfg and Supply Cha | SSale | −23.00 | $424.14 | $9.76K | Yes (planned) | Form 4 ↗ |
| 2026-06-10 | 2026-06-10 | LOEB GARY EVP & Chief Legal and Complian | SSale | −400.00 | $424.14 | $170K | Yes (planned) | Form 4 ↗ |
| 2026-06-10 | 2026-06-10 | Rosa David J. Chief Executive Officer (CEO) | FTax | −674.00 | $426.61 | $288K | No | Form 4 ↗ |
| 2026-06-10 | 2026-06-10 | Rosa David J., Chief Executive Officer (CEO) | MExercise | +1.36K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-10 | 2026-06-09 | Brosius Mark EVP & Chief Mfg and Supply Cha | SSale | −23.00 | $421.13 | $9.69K | Yes (planned) | Form 4 ↗ |
| 2026-06-10 | 2026-06-08 | Brosius Mark, EVP & Chief Mfg and Supply Cha | SSale | −23.00 | $420.12 | $9.66K | Yes (planned) | Form 4 ↗ |
| 2026-06-02 | 2026-06-01 | Jeddi Iman SVP & GM da Vinci Platforms & | SSale | −5.63K | $420.55 | $2.37M | Yes (planned) | Form 4 ↗ |
| 2026-06-02 | 2026-06-01 | Jeddi Iman, SVP & GM da Vinci Platforms & | MExercise | +5.63K | $77.00 | $433K | Yes (planned) | Form 4 ↗ |
| 2026-05-22 | 2026-05-22 | Brosius Mark EVP & Chief Mfg and Supply Cha | SSale | −18.00 | $439.80 | $7.92K | Yes (planned) | Form 4 ↗ |
| 2026-05-22 | 2026-05-21 | Brosius Mark, EVP & Chief Mfg and Supply Cha | SSale | −18.00 | $446.04 | $8.03K | Yes (planned) | Form 4 ↗ |
| 2026-05-20 | 2026-05-20 | Brosius Mark EVP & Chief Mfg and Supply Cha | SSale | −18.00 | $440.38 | $7.93K | Yes (planned) | Form 4 ↗ |
| 2026-05-20 | 2026-05-19 | Brosius Mark, EVP & Chief Mfg and Supply Cha | SSale | −18.00 | $440.70 | $7.93K | Yes (planned) | Form 4 ↗ |
| 2026-05-20 | 2026-05-18 | Brosius Mark, EVP & Chief Mfg and Supply Cha | SSale | −18.00 | $422.47 | $7.60K | Yes (planned) | Form 4 ↗ |
| 2026-05-11 | 2026-05-11 | LOEB GARY EVP & Chief Legal and Complian | SSale | −400.00 | $446.95 | $179K | Yes (planned) | Form 4 ↗ |
| 2026-04-30 | 2026-04-30 | Reed Monica P Director | MExercise | +531.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-30 | 2026-04-30 | Ladd Amy L Director | MExercise | +531.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-30 | 2026-04-30 | Kolli Sreelakshmi Director | MExercise | +531.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-30 | 2026-04-30 | Leonard Keith R Director | MExercise | +531.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-30 | 2026-04-30 | Johnson Amal M Director | MExercise | +531.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-30 | 2026-04-30 | BARRATT CRAIG H Director | MExercise | +750.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-30 | 2026-04-30 | Beery Joseph C Director | MExercise | +531.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-30 | 2026-04-30 | CHEW LEWIS Director | MExercise | +531.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-30 | 2026-04-30 | NACHTSHEIM JAMI K Director | MExercise | +531.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-29 | 2026-04-29 | Ladd Amy L Director | SSale | −119.00 | $463.50 | $55.2K | Yes (planned) | Form 4 ↗ |
| 2026-04-29 | 2026-04-28 | Ladd Amy L, Director | SSale | −500.00 | $473.46 | $237K | Yes (planned) | Form 4 ↗ |
| 2026-03-11 | 2026-03-10 | Curet Myriam EVP & Chief Medical Officer | SSale | −105.00 | $493.95 | $51.9K | Yes (planned) | Form 4 ↗ |
| 2026-03-11 | 2026-03-10 | Curet Myriam, EVP & Chief Medical Officer | MExercise | +105.00 | $229.39 | $24.1K | Yes (planned) | Form 4 ↗ |
| 2026-03-10 | 2026-03-09 | Brosius Mark SVP & Chief Mfg and Supply Cha | SSale | −645.00 | $485.01 | $313K | Yes (planned) | Form 4 ↗ |
| 2026-03-10 | 2026-03-06 | Brosius Mark, SVP & Chief Mfg and Supply Cha | SSale | −648.00 | $490.19 | $318K | Yes (planned) | Form 4 ↗ |
| 2026-03-05 | 2026-03-05 | Brosius Mark SVP & Chief Mfg and Supply Cha | SSale | −648.00 | $495.20 | $321K | Yes (planned) | Form 4 ↗ |
| 2026-03-05 | 2026-03-04 | Brosius Mark, SVP & Chief Mfg and Supply Cha | SSale | −2.36K | $498.68 | $1.18M | Yes (planned) | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | Brosius Mark, SVP & Chief Mfg and Supply Cha | SSale | −648.00 | $488.10 | $316K | Yes (planned) | Form 4 ↗ |
| 2026-02-27 | 2026-02-27 | WADORS PATRICIA L SVP Chief Human Resources Offi | SSale | −220.00 | $499.71 | $110K | Yes (planned) | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | Jeddi Iman SVP & GM da Vinci Platforms & | FTax | −341.00 | $506.17 | $173K | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | Jeddi Iman, SVP & GM da Vinci Platforms & | MExercise | +687.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | Jeddi Iman, SVP & GM da Vinci Platforms & | FTax | −631.00 | $506.17 | $319K | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | Jeddi Iman, SVP & GM da Vinci Platforms & | MExercise | +1.62K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | Brosius Mark SVP & Chief Mfg and Supply Cha | FTax | −483.00 | $506.17 | $244K | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | Brosius Mark, SVP & Chief Mfg and Supply Cha | MExercise | +973.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | Brosius Mark, SVP & Chief Mfg and Supply Cha | FTax | −805.00 | $506.17 | $407K | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | Brosius Mark, SVP & Chief Mfg and Supply Cha | MExercise | +1.62K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | Widman Fredrik VP Corporate Controller | FTax | −188.00 | $506.17 | $95.2K | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | Widman Fredrik, VP Corporate Controller | MExercise | +378.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | Widman Fredrik, VP Corporate Controller | FTax | −303.00 | $506.17 | $153K | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | Widman Fredrik, VP Corporate Controller | MExercise | +611.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | Charlton Henry L EVP & Chief Commercial and Mkt | FTax | −459.00 | $506.17 | $232K | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | Charlton Henry L, EVP & Chief Commercial and Mkt | MExercise | +1.03K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | Charlton Henry L, EVP & Chief Commercial and Mkt | FTax | −765.00 | $506.17 | $387K | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | Charlton Henry L, EVP & Chief Commercial and Mkt | MExercise | +1.72K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | Curet Myriam EVP & Chief Medical Officer | FTax | −795.00 | $506.17 | $402K | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | Curet Myriam, EVP & Chief Medical Officer | MExercise | +1.60K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | Curet Myriam, EVP & Chief Medical Officer | FTax | −1.51K | $506.17 | $766K | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | Curet Myriam, EVP & Chief Medical Officer | MExercise | +3.05K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | LOEB GARY EVP & Chief Legal and Complian | FTax | −455.00 | $506.17 | $230K | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | LOEB GARY, EVP & Chief Legal and Complian | MExercise | +916.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | LOEB GARY, EVP & Chief Legal and Complian | FTax | −757.00 | $506.17 | $383K | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | LOEB GARY, EVP & Chief Legal and Complian | MExercise | +1.53K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | Rosa David J. Chief Executive Officer (CEO) | FTax | −1.14K | $506.17 | $575K | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | Rosa David J., Chief Executive Officer (CEO) | MExercise | +2.29K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | Rosa David J., Chief Executive Officer (CEO) | FTax | −1.89K | $506.17 | $958K | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | Rosa David J., Chief Executive Officer (CEO) | MExercise | +3.82K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | Samath Jamie EVP & CFO & Enterprise Technol | FTax | −738.00 | $506.17 | $374K | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | Samath Jamie, EVP & CFO & Enterprise Technol | MExercise | +1.49K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | Samath Jamie, EVP & CFO & Enterprise Technol | FTax | −900.00 | $506.17 | $456K | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | Samath Jamie, EVP & CFO & Enterprise Technol | MExercise | +1.91K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | GUTHART GARY S Director | FTax | −1.70K | $506.17 | $862K | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | GUTHART GARY S, Director | MExercise | +3.43K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | GUTHART GARY S, Director | FTax | −2.46K | $506.17 | $1.25M | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | GUTHART GARY S, Director | MExercise | +4.96K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | WADORS PATRICIA L SVP Chief Human Resources Offi | FTax | −238.00 | $506.17 | $120K | Yes (planned) | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | WADORS PATRICIA L, SVP Chief Human Resources Offi | MExercise | +458.00 | $0.00 | $0.00 | Yes (planned) | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also ISRG’s full analysis or the market-wide insider trading feed. The tabs above jump to ISRG’s other SEC data.
Source: SEC Form 4 filings for ISRG, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.